Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 6,321 | 6,947 | 4,216 | 6,732 | 1,818 |
| Income taxes - deferred | 918 | 823 | 1,514 | 2,274 | 67 |
| Accounts receivable | 5,877 | -4,024 | -1,259 | 1,970 | 1,140 |
| Other Working Capital | 8,747 | -5,145 | -2,103 | 5,584 | -1,602 |
| Other Operating Activity | 3,201 | 6,722 | 3,187 | 5,417 | -720 |
| Operating Cash Flow | $25,064 | $5,323 | $5,555 | $21,977 | $704 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,967 | -2,975 | -10,393 | -11,275 | -16,205 |
| Purchase Of Investment | -187 | -1,503 | N/A | N/A | N/A |
| Sale Of Investment | 345 | 631 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,809 | $-3,847 | $-10,393 | $-11,275 | $-16,205 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8,636 | -2,393 | -1,770 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 0 | 7,104 | N/A |
| Common Stock Repurchased | -5,373 | N/A | N/A | N/A | N/A |
| Dividend Paid | -3,980 | 0 | -1,279 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -1,932 | 6,712 |
| Financing Cash Flow | $-17,989 | $-2,393 | $-3,048 | $5,172 | $6,712 |
| Exchange Rate Effect | -15 | -80 | 72 | -95 | -11 |
| Beginning Cash Position | 5,071 | 5,841 | 12,840 | 0 | 8,800 |
| End Cash Position | 10,322 | 4,844 | 5,025 | 15,779 | 0 |
| Net Cash Flow | $5,266 | $-917 | $-7,887 | $15,874 | $-8,789 |
| Free Cash Flow | |||||
| Operating Cash Flow | 25,064 | 5,323 | 5,555 | 21,977 | 704 |
| Capital Expenditure | -2,876 | -3,004 | -10,582 | -11,388 | -17,879 |
| Free Cash Flow | 22,188 | 2,320 | -5,027 | 10,589 | -17,176 |